SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 3.85%2.7B | 2.83%3.81B | 2.25%3.59B | 2.12%14.81B | 91.70%7.18B | -27.99%2.6B | 3.14%3.71B | -5.23%3.51B | 19.43%14.51B | 30.22%3.75B |
Operating revenue | 3.85%2.7B | 2.83%3.81B | 2.25%3.59B | 2.12%14.81B | 91.70%7.18B | -27.99%2.6B | 3.14%3.71B | -5.23%3.51B | 19.43%14.51B | 30.22%3.75B |
Cost of revenue | 7.97%1.67B | -8.28%2.38B | -1.47%2.21B | 4.22%9.84B | 122.91%5.25B | -39.82%1.54B | 16.78%2.6B | -5.13%2.24B | 27.12%9.44B | 27.06%2.36B |
Gross profit | -2.18%1.03B | 28.80%1.43B | 8.78%1.39B | -1.80%4.98B | 38.69%1.93B | 1.05%1.06B | -18.96%1.11B | -5.42%1.28B | 7.33%5.07B | 35.95%1.39B |
Operating expense | 0.68%883M | 5.76%1.19B | 4.71%1.2B | 3.23%4.61B | 84.27%1.94B | -19.69%877M | 0.98%1.13B | -4.66%1.15B | 32.14%4.46B | 5.08%1.06B |
Selling and administrative expenses | 1.34%754M | 5.91%1.02B | 3.22%1.03B | 2.05%3.94B | 85.13%1.67B | -20.94%744M | -0.62%964M | -5.42%995M | 35.64%3.86B | 4.40%901M |
-General and administrative expense | ---- | ---- | ---- | 2.05%3.94B | ---- | ---- | ---- | ---- | 35.64%3.86B | ---- |
Research and development costs | -3.01%129M | 4.85%173M | 7.32%176M | 10.80%667M | 79.22%276M | -11.92%133M | 11.49%165M | 9.33%164M | 13.37%602M | 14.07%154M |
Other operating expenses | ---- | ---- | 76.92%-3M | ---- | ---- | ---- | ---- | ---13M | ---- | ---- |
Operating profit | -16.20%150M | 1,416.67%237M | 44.96%187M | -38.84%370M | -105.71%-19M | 480.85%179M | -107.11%-18M | -11.64%129M | -54.99%605M | 1,858.82%333M |
Net non-operating interest income expense | 31.50%-87M | 31.45%-85M | 33.33%-78M | -11.90%-442M | 35.90%-75M | -22.12%-127M | -39.33%-124M | -37.65%-117M | -104.66%-395M | -56.00%-117M |
Non-operating interest income | 55.56%14M | 137.50%19M | 150.00%25M | 250.00%70M | 437.50%43M | 80.00%9M | 100.00%8M | 233.33%10M | 42.86%20M | 100.00%8M |
Non-operating interest expense | -25.74%101M | -21.21%104M | -18.90%103M | 23.37%512M | -5.60%118M | 24.77%136M | 41.94%132M | 44.32%127M | 100.48%415M | 58.23%125M |
Other net income (expense) | -50.00%6M | -897.56%-409M | 250.00%7M | 98.88%-32M | 42.59%-31M | 100.41%12M | -174.55%-41M | -93.94%2M | -8,071.43%-2.86B | -170.00%-54M |
Gain on sale of security | 0.00%-7M | ---- | -11.11%-10M | -742.86%-45M | 129.17%7M | -133.33%-7M | -243.48%-33M | -190.00%-9M | 129.17%7M | -41.18%-24M |
Special income (charges) | -6.67%14M | -3,709.09%-419M | ---- | 98.83%-34M | -20.00%-72M | 100.52%15M | -137.93%-11M | ---- | -290,000.00%-2.9B | -5,900.00%-60M |
-Less:Restructuring and merger&acquisition | ---5M | 0.00%-1M | ---- | 51.28%-19M | 0.00%-5M | --0 | 90.91%-1M | ---- | -550.00%-39M | ---5M |
-Less:Impairment of capital assets | ---- | --430M | ---- | --0 | ---- | ---- | --0 | ---- | --2.81B | --27M |
-Less:Other special charges | 40.00%-9M | 9.09%-10M | ---- | -97.62%1M | 123.53%38M | -131.25%-15M | 38.89%-11M | ---- | 500.00%42M | --17M |
-Write off | --0 | --0 | ---- | --52M | --39M | --0 | --23M | ---- | --0 | --0 |
-Gain on sale of business | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---86M | ---21M |
Other non- operating income (expenses) | -125.00%-1M | 233.33%10M | 54.55%17M | 38.24%47M | 13.33%34M | 300.00%4M | 0.00%3M | 83.33%11M | 440.00%34M | 1,600.00%30M |
Income before tax | 7.81%69M | -40.44%-257M | 728.57%116M | 96.11%-103M | -176.54%-124M | 102.10%64M | -183.56%-183M | -85.11%14M | -337.46%-2.65B | 307.69%162M |
Income tax | -70.37%8M | 440.00%54M | 450.00%77M | -950.00%-34M | -616.67%-93M | 150.00%27M | -70.59%10M | -33.33%14M | -95.18%4M | 131.03%18M |
Net income | -94.27%144M | -123.74%-311M | -13.33%39M | 210.00%2.66B | 32.97%246M | 185.58%2.51B | -154.51%-139M | -38.36%45M | -286.95%-2.42B | -23.55%185M |
Net income continuous Operations | 64.86%61M | -61.14%-311M | --39M | 97.40%-69M | -121.53%-31M | 101.24%37M | -204.32%-193M | --0 | -356.92%-2.65B | 820.00%144M |
Net income discontinuous operations | -96.65%83M | --0 | --0 | 1,072.53%2.73B | 575.61%277M | 4,240.35%2.47B | -22.86%54M | --45M | -11.07%233M | --41M |
Minority interest income | 33.33%4M | 50.00%3M | 100.00%2M | -41.67%7M | -75.00%1M | 0.00%3M | -33.33%2M | -50.00%1M | 9.09%12M | 0.00%4M |
Net income attributable to the parent company | -94.42%140M | -122.70%-314M | -15.91%37M | 209.17%2.66B | 35.36%245M | 185.39%2.51B | -155.95%-141M | -38.03%44M | -289.49%-2.43B | -23.95%181M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -94.42%140M | -122.70%-314M | -15.91%37M | 209.17%2.66B | 35.36%245M | 185.39%2.51B | -155.95%-141M | -38.03%44M | -289.49%-2.43B | -23.95%181M |
Basic earnings per share | -94.55%0.27 | -121.43%-0.62 | -22.22%0.07 | 208.70%5.25 | 33.33%0.48 | 184.91%4.95 | -156.00%-0.28 | -35.71%0.09 | -288.67%-4.83 | -25.00%0.36 |
Diluted earnings per share | -94.52%0.27 | -121.43%-0.62 | -22.22%0.07 | 208.70%5.25 | 33.33%0.48 | 184.56%4.93 | -156.00%-0.28 | -35.71%0.09 | -290.91%-4.83 | -23.40%0.36 |
Dividend per share | 0.00%0.29 | 0.00%0.29 | 0.00%0.29 | 0.87%1.16 | 0.00%0.29 | 0.00%0.29 | 0.00%0.29 | 3.57%0.29 | 5.99%1.15 | 3.57%0.29 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |